European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery · 1995
Pharmacological prophylaxis against postoperative graft occlusion after peripheral vascular surgery: a world-wide survey.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lindblad B, Wakefield T W, Stanley T J, Bergqvist D, Nichol B J, Greenfield L J, Stanley J C, Bergentz S E
Аннотация
OBJECTIVES: To define current practice regarding the use of pharmacological prophylaxis to prevent postoperative graft occlusion.
DESIGN: Prospective open questionnaire.
MATERIALS AND METHODS: Questionnaires regarding this subject were sent to vascular surgeons throughout the world to analyse current practice.
RESULTS: 651 questionnaires were returned with a response rate of 62% and form the basis for this report. Data from 100,334 vascular reconstructions were reported in this survey. Prophylaxis against postoperative graft occlusions was common. Treatment periods were usually greater than 1 year. Among carotid surgery patients, 82% received prophylaxis, consisting mainly of low-dose acetysalicylic acid (ASA). In Mid-Europe the use of oral anticoagulation was more common than in other regions (p < 0.001). Among aneurysm surgery patients, 38% received prophylaxis. For infrainguinal bypass, ASA in low dose was the most commonly used agent worldwide. However, oral anticoagulation was more frequent in Mid-Europe, in contrast to South America where the combination of ASA and dipyridamole was most common. Considerable geographical differences regarding patient selection, the frequency of specific procedures and operative techniques existed.
CONCLUSIONS: Important world-wide differences exist regarding prophylaxis for postoperative graft occlusion.
DESIGN: Prospective open questionnaire.
MATERIALS AND METHODS: Questionnaires regarding this subject were sent to vascular surgeons throughout the world to analyse current practice.
RESULTS: 651 questionnaires were returned with a response rate of 62% and form the basis for this report. Data from 100,334 vascular reconstructions were reported in this survey. Prophylaxis against postoperative graft occlusions was common. Treatment periods were usually greater than 1 year. Among carotid surgery patients, 82% received prophylaxis, consisting mainly of low-dose acetysalicylic acid (ASA). In Mid-Europe the use of oral anticoagulation was more common than in other regions (p < 0.001). Among aneurysm surgery patients, 38% received prophylaxis. For infrainguinal bypass, ASA in low dose was the most commonly used agent worldwide. However, oral anticoagulation was more frequent in Mid-Europe, in contrast to South America where the combination of ASA and dipyridamole was most common. Considerable geographical differences regarding patient selection, the frequency of specific procedures and operative techniques existed.
CONCLUSIONS: Important world-wide differences exist regarding prophylaxis for postoperative graft occlusion.